You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

TRI LO SPRINTEC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Tri Lo Sprintec, and what generic alternatives are available?

Tri Lo Sprintec is a drug marketed by Barr Labs Inc and is included in one NDA.

The generic ingredient in TRI LO SPRINTEC is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRI LO SPRINTEC?
  • What are the global sales for TRI LO SPRINTEC?
  • What is Average Wholesale Price for TRI LO SPRINTEC?
Summary for TRI LO SPRINTEC
Drug patent expirations by year for TRI LO SPRINTEC
Recent Clinical Trials for TRI LO SPRINTEC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of PennsylvaniaPhase 1
Society of Family PlanningPhase 1
American Heart AssociationPhase 4

See all TRI LO SPRINTEC clinical trials

US Patents and Regulatory Information for TRI LO SPRINTEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr Labs Inc TRI LO SPRINTEC ethinyl estradiol; norgestimate TABLET;ORAL-28 076784-001 Jun 29, 2009 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.